ROCHE HOLDING AG
ROCHE HOLDING AG
Share · CH0012032113 · 851311 (XSWX)
Overview
No Price
08.09.2025 13:30
1 day
-
1 week
-
1 month
-
3 months
-
6 months
-
Year to date
-
1 year
-
2 years
-
3 years
-
4 years
-
5 years
-
10 years
-
20 years
-
Max
-
Current Prices from ROCHE HOLDING AG
ExchangeTickerCurrencyLast TradePriceDaily Change
XLON: London
London
0QQ6.L
CHF
08.09.2025 13:16
284,80 CHF
-5,80 CHF
-2,00 %
Invested Funds

The following funds have invested in ROCHE HOLDING AG:

Fund
iShares Edge MSCI Europe Minimum Volatility ESG UCITS ETF USD Hedged (Acc)
Vol. in million
13,97
Percentage (%)
1,70 %
Fund
iShares Edge MSCI Europe Minimum Volatility ESG UCITS ETF EUR (Acc)
Vol. in million
339,25
Percentage (%)
1,70 %
Fund
iShares Edge MSCI Europe Minimum Volatility UCITS ETF EUR (Dist)
Vol. in million
159,69
Percentage (%)
1,03 %
Fund
iShares MSCI Europe Health Care Sector UCITS ETF EUR (Acc)
Vol. in million
371,48
Percentage (%)
0,85 %
Fund
iShares Edge MSCI Europe Quality Factor UCITS ETF EUR (Dist)
Vol. in million
11,44
Percentage (%)
0,27 %
Company Profile for ROCHE HOLDING AG Share
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. It has a research collaboration agreement with Synlogic, Inc. for the discovery of a novel synthetic biotic for the treatment of inflammatory bowel disease (IBD). The company was founded in 1896 and is headquartered in Basel, Switzerland.

Company Data

Name ROCHE HOLDING AG
Company Roche Holding AG
Website https://www.roche.com
Primary Exchange XSWX SIX
WKN 851311
ISIN CH0012032113
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - General
CEO Thomas Schinecker
Market Capitalization 199 Mrd.
Country Switzerland
Currency CHF
Employees 103,2 T
Address Konzern Hauptsitz, 4070 Basel
IPO Date 2014-03-07

Ticker Symbols

Name Symbol
Frankfurt RHO.F
London 0QQ6.L
XETRA RHO.DE
More Shares
Investors who hold ROCHE HOLDING AG also have the following shares in their portfolio:
ALFA BOND ISSUANCE PLC 7.75% LOAN NTS 28/04/21 (144A)
ALFA BOND ISSUANCE PLC 7.75% LOAN NTS 28/04/21 (144A) Bond
AMAZON.CO INC
AMAZON.CO INC Share
ANALOG DEVICES 16/21
ANALOG DEVICES 16/21 Bond
APPLE INC
APPLE INC Share
DANAHER CORP
DANAHER CORP Share
HAPAG-LLOYD AG
HAPAG-LLOYD AG Share
INSTRUMENT DE000JA1QEN7
INSTRUMENT DE000JA1QEN7 Unbekannt
META PLATFORMS INC
META PLATFORMS INC Share
MICROSOFT CORP
MICROSOFT CORP Share
NINTENDO CO LTD
NINTENDO CO LTD Share
Novo Nordisk
Novo Nordisk Share
NVIDIA CORP
NVIDIA CORP Share
SQUARE INC A
SQUARE INC A Share
TESLA INC
TESLA INC Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025